First of all, after thousands of years of clinical practice, traditional Chinese medicine prescriptions have unquestionably proven their inherent rationality. But what about us in China? But they think it is unscientific, and they have to use the standards of Western medicine to test it. As we all know, the clinical trial of a new drug is not something ordinary companies can do. Not only does it take a long time, but it also costs a lot, which seriously restricts the traditional Chinese medicine prescription. The development of value has seriously delayed the production and research of Jingfang.
On the other hand, Japan has opened up the production of traditional Chinese medicines very early. The Japanese have summarized China’s thousands of years of clinical experience and used scientific methods to conduct some clinical verifications, thereby selecting some traditional Chinese medicines. Through large-scale production, China's prescriptions will shine in Japan and earn a lot of money for Japanese pharmaceutical companies. For example, the ancient Chinese prescription "Liu Shen Wan" was modified by Japan to develop the "Xinjiu Xin Dan", which was once popular all over the world and was hailed as the "life-saving miracle drug" with annual sales of more than 100 million US dollars. Japan's long-established Kampo medicine "Shoro Pills" has also been sold back to China. Among the countries that have applied for TCM patents from China, Japan, South Korea, the United States, and Germany are the most enthusiastic.